Biotech

All Articles

Rakovina deepens AI concentrate with collab to pick cancer cells intendeds

.5 months after Rakovina Rehabs rotated towards expert system, the cancer-focused biotech has partic...

Ascendis' dwarfism medication hits in stage 3, threatens BioMarin

.Ascendis Pharma has actually emerged as a potential risk to BioMarin's Voxzogo, reporting phase 3 g...

Despite ph. 3 miss, Alkeus observes path ahead for eye illness asset

.Though Alkeus Pharmaceuticals' oral eye health condition property fell short to considerably decrea...

Kairos goes social with $6M IPO to fund trials of cancer cells medicine

.Along with a trio of biotechs hitting the Nasdaq on Friday, it was actually easy to skip a smaller-...

Vaccine as well as Keytruda combination effective in squamous tissue cancer

.Immune system gate preventions are the superheroes of cancer cells therapy. Medicines like Bristol ...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings and...

Regeneron's Opdualag rival reveals 57% feedback rate

.Regeneron is actually back along with lasting consequence for its own LAG-3 prevention and also PD-...

AstraZeneca posts data on in-house rivals to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed a very early examine the efficiency of its own in-house antibody...

iTeos- GSK's TIGIT star shows significant improvement

.After introducing a period 3 launch based upon beneficial midstage outcomes, iTeos and also GSK are...

More collaborative FDA can easily speed up unusual disease R&ampD: document

.The FDA needs to be more available as well as collective to unleash a rise in approvals of unusual ...